返回
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.（2315.HK）價格
2315.HK 股價走勢圖
BIOCYTOGEN-B (2315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$43.28
-0.55%
$-0.24
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$43
開盤價
$43.52
當日範圍
$41 - $43.88
52週區間
$7.25 - $48.26
交易量
657.0K
平均成交量
1.0M
每股盈餘 (TTM)
0.37
股息收益率
--
市值
$4.6B
什麼是 BIOCYTOGEN-B？
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.